Handelsavisen
prelaunch
Companies Healthcare 099190.KQ
09
099190.KQ KOSDAQ Medical Equipment, Supplies & Distribution

I Sens Inc

$19 220,00
Open in Charts → Attach watcher ⌖
KRW
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
530,6B KRW
P/E
EV / Rev
Div yield
0,47 %
Op margin
0,2 %
ROE
-1,6 %
Net margin
-1,6 %
Debt / equity
0,55
Beta
52w range
Volume
Day range
Prev close
Open
Next earnings
Ex-dividend
TR 1Y
About

I Sens Inc is a South Korean company specializing in the development and distribution of medical equipment and supplies, primarily focused on healthcare services and equipment.

Business. I Sens Inc (099190.KQ) is a healthcare services and equipment company operating within the medical equipment, supplies, and distribution industry. The firm generates revenue through the sale of products, though specific operating segments and geographic breakdowns are not disclosed. Headquartered in South Korea, the company is primarily listed on the KOSDAQ exchange.

Classification92 %
SectorHealthcare
Business sectorHealthcare Services & Equipment
IndustryMedical Equipment, Supplies & Distribution
ActivityHealthcare Services & Equipment
Generated · model-assisted
Sell-side consensus
BUY2 analysts
2 buy0 hold0 sell
Avg 12m price target36 000,00

Analyst recommendations

2 analysts · consensus Buy
Buy2
Hold0
Sell0
12-month price target
36 000,00
Consensus of sell-side coverage.
Upcoming events
— missing data
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
Buy
2 analysts · indicative
Ownership
not yet wired
Profitability
-1,6 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning 099190.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care · THIS SECTOR+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to 099190.KQ. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    I Sens Inc (099190.KQ) is a healthcare services and equipment company operating within the medical equipment, supplies, and distribution industry. The firm generates revenue through the sale of products, though specific operating segments and geographic breakdowns are not disclosed. Headquartered in South Korea, the company is primarily listed on the KOSDAQ exchange.

    Classification92 %
    SectorHealthcare
    Business sectorHealthcare Services & Equipment
    IndustryMedical Equipment, Supplies & Distribution
    ActivityHealthcare Services & Equipment
    AI synthesis
    GENERATED

    I Sens Inc's capital structure is characterized by a debt-to-equity ratio of 0.55, indicating a moderate level of leverage. The company's liquidity position is marked by a current ratio of 1.55, suggesting it has sufficient short-term assets to cover its short-term liabilities. However, the company's free cash flow is negative at -20,719,926,880 KRW, which may indicate challenges in generating sufficient cash from operations to fund its capital expenditures and other obligations.

    In terms of profitability, I Sens Inc is underperforming relative to industry standards. The company's return on equity (ROE) is -1.63%, and its return on assets (ROA) is -0.89%, both of which are negative, indicating that the company is not generating returns that exceed its cost of capital. The net income is also negative at -5,148,914,770 KRW, further highlighting the company's financial distress.

    The company's revenue is primarily concentrated in a single geographic region, as there is no detailed breakdown of geographic exposure provided in the available data. This lack of diversification could pose a risk if the company's primary market experiences economic downturns or regulatory changes.

    The growth trajectory of I Sens Inc appears to be challenging, as the company is currently reporting a net loss. The available data does not provide specific outlook figures for the current or next fiscal year, but the negative net income and free cash flow suggest that the company may face difficulties in achieving positive growth in the near term.

    The risk assessment for I Sens Inc indicates a medium level of liquidity risk and a low level of dilution risk. The company's key financial flags include a negative net cash position after subtracting total debt, which could impact its ability to meet short-term obligations. The dilution risk is considered low, but the company's negative net income and free cash flow may necessitate additional financing, which could lead to dilution in the future.

    Recent events and filings for I Sens Inc include a mean price target of 36,000 KRW from analysts, with a median price target of 36,000 KRW. The high and low price targets are 40,000 KRW and 32,000 KRW, respectively. The mean recommendation from analysts is 1.50, indicating a generally positive outlook, with one strong-buy and one buy recommendation.

    Key takeaways
    • I Sens Inc has a moderate level of leverage with a debt-to-equity ratio of 0.55.
    • The company is currently unprofitable, with a negative return on equity and return on assets.
    • The company's liquidity position is moderate, with a current ratio of 1.55.
    • I Sens Inc's growth trajectory is uncertain due to its negative net income and free cash flow.
    • The company faces a medium liquidity risk and a low dilution risk.
    • Analysts have a generally positive outlook on the company, with a mean price target of 36,000 KRW.
    • margin_outlook_rationale: The company's negative net income and free cash flow suggest that its margins are under pressure, driven by operational inefficiencies and high costs.

    Bull / Bear case

    Generated · model-assisted
    — missing data

    In focus — financials by report

    Valuation

    Market price
    $19 220,00
    Market cap
    $530.61B
    Enterprise value
    $659.41B
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    32.8x
    P / B
    1.7x
    P / Tangible book
    1.7x
    Tangible book
    $315.25B
    Net cash
    -$128.80B
    Current ratio
    1.6
    Debt / equity
    0.6
    ROA
    -0.9%
    ROE
    -1.6%
    Cash conversion
    -391.0%
    CapEx / revenue
    -9.0%
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Next quarternear-term
    Earnings · next quarterconf 45 %
    EPS
    Consensus EPS
    28,70
    Predicted surprise
    +0,00
    Beat probability
    45 %
    Analysts
    2
    Other metrics
    Revenue
    no estimate
    Segment revenue
    no estimate
    Margin
    no estimate
    Segment margin
    no estimate
    as of 2026-05-20 · Earnings Surprise V1
    Period note: consensus is not fiscal-period-aligned at source — read as consensus vs the last reported actual, not a calibrated same-quarter surprise.
    Full fiscal year~1 year ahead
    Full fiscal year · our forecast vs guidance vs consensus
    MetricOur forecastGuidanceConsensus
    EPSno estimateno estimate28,70
    Revenueno estimateno estimate333,8B KRW
    Operating incomeno estimateno estimate4,2B KRW
    Full-year consensus mean (period as reported by source) · consensus in KRW. Company-level full-year forecast and management guidance are not yet modelled at scale — shown as "no estimate", never inferred.
    Probabilistic model output — not investment advice. · generated 2026-08-04

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Consensus distribution

    sell-side coverage
    Recommendation distribution2 analysts
    Strong buy1
    Buy1
    Hold0
    Sell0
    Strong sell0
    12-month price target$36 000,00 · Median $36 000,00
    Low $32 000,00High $40 000,00
    Operating income · consensus4,2B KRW
    EPS surprise
    −751,6 %
    reported vs consensus · miss
    Revenue surprise
    −5,5 %
    reported vs consensus · miss

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    Low$32 000,00
    Mean$36 000,00
    Median$36 000,00
    High$40 000,00
    Spot$19 220,00
    +87.3 %implied to mean12-month sell-side price targets · ▲ spot

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskMedium
    Filing-based flags
    • Net cash is negative after subtracting total debt.

    Benchmarks vs cohort

    Op Margin0,2 %Below median
    Net Margin-1,6 %Below median
    ROE-1,6 %Below median
    Capex / Rev-9,0 %Below median
    D/E0,55Bottom quartile
    Cash Conv-3,91Bottom quartile

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Ev To Operating Cash Flow
      enterprise_value / operating_cash_flow
    • Return On Equity
      net_income / total_equity
    • Price To Book
      market_price / (adjusted_book_value / shares_outstanding_diluted)
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Market Price
      input from market-data provider (delayed close or quote-shim mid)
    • Market Cap
      market_price * shares_outstanding_diluted
    Source documents
    • I Sens Inc Market data — financials · 2026-05-26
    • I Sens Inc Market data — analyst estimates · 2026-05-26

    Ownership & reference

    Insider activity

    — missing data

    Short positioning

    — missing data

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    099190.KQCanonical
    KOSDAQ · KRW

    Intel & risk

    PredictorBeat prob45 %Surprise+0,00Full forecast →
    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskMedium
    Net cash is negative after subtracting total debt.

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    2026-06-30 03:38 UTCEARNINGSUpcomingForecast: earnings_forecast (90d)
    2026-06-20 12:34 UTCANALYSTAnalyst coverage initiated
    2026-06-20 12:34 UTCANALYSTAnalyst coverage initiated
    2026-06-20 12:34 UTCANALYSTAnalyst coverage initiated
    The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage